purchase customization

1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2022 VS 2029
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top Biosimilars Players in Global Market
3.2 Top Global Biosimilars Companies Ranked by Revenue
3.3 Global Biosimilars Revenue by Companies
3.4 Global Biosimilars Sales by Companies
3.5 Global Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Biosimilars Sales, 2024-2029
4.3.3 By Type - Global Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic and Autoimmune Disorders
5.1.6 Others
5.2 By Application - Global Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Biosimilars Sales, 2024-2029
5.3.3 By Application - Global Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Biosimilars Sales, 2024-2029
6.3.3 By Region - Global Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America Biosimilars Sales, 2018-2029
6.4.3 US Biosimilars Market Size, 2018-2029
6.4.4 Canada Biosimilars Market Size, 2018-2029
6.4.5 Mexico Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe Biosimilars Sales, 2018-2029
6.5.3 Germany Biosimilars Market Size, 2018-2029
6.5.4 France Biosimilars Market Size, 2018-2029
6.5.5 U.K. Biosimilars Market Size, 2018-2029
6.5.6 Italy Biosimilars Market Size, 2018-2029
6.5.7 Russia Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries Biosimilars Market Size, 2018-2029
6.5.9 Benelux Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia Biosimilars Sales, 2018-2029
6.6.3 China Biosimilars Market Size, 2018-2029
6.6.4 Japan Biosimilars Market Size, 2018-2029
6.6.5 South Korea Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia Biosimilars Market Size, 2018-2029
6.6.7 India Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America Biosimilars Sales, 2018-2029
6.7.3 Brazil Biosimilars Market Size, 2018-2029
6.7.4 Argentina Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biosimilars Sales, 2018-2029
6.8.3 Turkey Biosimilars Market Size, 2018-2029
6.8.4 Israel Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia Biosimilars Market Size, 2018-2029
6.8.6 UAE Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Biocon
7.3.1 Biocon Company Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Biocon Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Company Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Fresenius Kabi AG Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck KgaA
7.7.1 Merck KgaA Company Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.7.4 Merck KgaA Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Merck KgaA Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Company Summary
7.11.2 Dr. Reddy's Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy's Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy's Laboratories Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.12 Amgen
7.12.1 Amgen Company Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Amgen Key News & Latest Developments
7.13 Celltrion
7.13.1 Celltrion Company Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 Celltrion Key News & Latest Developments
7.14 Samsung Biologics
7.14.1 Samsung Biologics Company Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Samsung Biologics Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Probiomed
7.16.1 Probiomed Company Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Probiomed Key News & Latest Developments
7.17 Apotex
7.17.1 Apotex Company Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 Apotex Key News & Latest Developments
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Company Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Chong Kun Dang Key News & Latest Developments
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Company Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 JCR Pharmaceuticals Key News & Latest Developments
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Company Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.20.5 Gan & Lee Pharmaceuticals Key News & Latest Developments
7.21 Gedeon Richter
7.21.1 Gedeon Richter Company Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2018-2023)
7.21.5 Gedeon Richter Key News & Latest Developments
7.22 Biocad
7.22.1 Biocad Company Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2018-2023)
7.22.5 Biocad Key News & Latest Developments
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Company Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2018-2023)
7.23.5 Coherus Bioscience Key News & Latest Developments
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Company Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2018-2023)
7.24.5 Stada Arzneimittel AG Key News & Latest Developments
8 Global Biosimilars Production Capacity, Analysis
8.1 Global Biosimilars Production Capacity, 2018-2029
8.2 Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars Supply Chain Analysis
10.1 Biosimilars Industry Value Chain
10.2 Biosimilars Upstream Market
10.3 Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer